Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy.
- DOI
- 10.1016/j.neuint.2022.105470
- Published
- 2023 Feb
- Container
- Neurochemistry international
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuint.2022.105470,
title = {Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy.},
author = {Ma S and Nakamura Y and Hisaoka-Nakashima K and Morioka N},
year = {2023},
journal = {Neurochemistry international},
doi = {10.1016/j.neuint.2022.105470},
url = {https://doi.org/10.1016/j.neuint.2022.105470}
}RIS
TY - JOUR TI - Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy. AU - Ma S AU - Nakamura Y AU - Hisaoka-Nakashima K AU - Morioka N PY - 2023 JO - Neurochemistry international DO - 10.1016/j.neuint.2022.105470 UR - https://doi.org/10.1016/j.neuint.2022.105470 ER -
APA
S, M., Y, N., K, H., & N, M. (2023). Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy.. Neurochemistry international. https://doi.org/10.1016/j.neuint.2022.105470
Source records
- pubmed · retrieved 2026-09-26T10:56:32.062Z